Stratégies thérapeutiques et recommandations pour la prise en charge des patients atteints de leucémie myéloïde chronique = Treatment and monitoring of patients with chronic myeloid leukemiaBORIES, Dominique; DEVERGIE, Agnès; ROUSSELOT, Philippe et al.Hématologie (Montrouge). 2003, Vol 9, Num 6, pp 497-512, issn 1264-7527, 16 p.Article

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid LeukemiaPREUDHOMME, Claude; GUILHOT, Joëlle; REA, Delphine et al.The New England journal of medicine. 2010, Vol 363, Num 26, pp 2511-2521, issn 0028-4793, 11 p.Article

Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phaseMALOISEL, F; GUERCI, A; ABGRALL, J. F et al.Leukemia. 2002, Vol 16, Num 4, pp 573-580, issn 0887-6924Article